Wai Chun Bio-Technology Issues Circular Covering Major and Discloseable Transactions, Advance to an Entity, and Upcoming EGM

Bulletin Express

Mar 31

Wai Chun Bio-Technology Limited released a bilingual circular on 31 March 2026 outlining four key matters: (1) Major Transactions, (2) Discloseable Transactions, (3) an Advance to an Entity, and (4) the Notice of an Extraordinary General Meeting (EGM).

The document is accessible on both the company’s website (www.0660.hk) and HKEX’s website (www.hkexnews.hk). Non-registered shareholders may request free printed copies through Union Registrars Limited, the Hong Kong branch share registrar, by written request or email.

Shareholders holding shares via banks, brokers, custodians, nominees, or HKSCC Nominees Limited can opt to receive future corporate communications electronically by providing a functional email address to their respective intermediaries. If no email address is supplied, electronic notification will not be sent.

Enquiries regarding the circular or the distribution arrangements can be directed to Union Registrars Limited at +852 2849 3399 during business hours, Monday to Friday (excluding Hong Kong public holidays).

The circular’s release precedes the forthcoming EGM, details of which—including date, time, and venue—are provided within the published document.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1179658578"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179658578\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1179658578?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 20:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179658578","market":"us","top_or_hot":-1,"title":"Wai Chun Bio-Technology Issues Circular Covering Major and Discloseable Transactions, Advance to an Entity, and Upcoming EGM","media":"Bulletin Express","content":"<p>Wai Chun Bio-Technology Limited released a bilingual circular on 31 March 2026 outlining four key matters: (1) Major Transactions, (2) Discloseable Transactions, (3) an Advance to an Entity, and (4) the Notice of an Extraordinary General Meeting (EGM).</p>\n<p>The document is accessible on both the company’s website (www.0660.hk) and HKEX’s website (www.hkexnews.hk). Non-registered shareholders may request free printed copies through Union Registrars Limited, the Hong Kong branch share registrar, by written request or email.</p>\n<p>Shareholders holding shares via banks, brokers, custodians, nominees, or HKSCC Nominees Limited can opt to receive future corporate communications electronically by providing a functional email address to their respective intermediaries. If no email address is supplied, electronic notification will not be sent.</p>\n<p>Enquiries regarding the circular or the distribution arrangements can be directed to Union Registrars Limited at +852 2849 3399 during business hours, Monday to Friday (excluding Hong Kong public holidays).</p>\n<p>The circular’s release precedes the forthcoming EGM, details of which—including date, time, and venue—are provided within the published document.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wai Chun Bio-Technology Issues Circular Covering Major and Discloseable Transactions, Advance to an Entity, and Upcoming EGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWai Chun Bio-Technology Issues Circular Covering Major and Discloseable Transactions, Advance to an Entity, and Upcoming EGM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-31 20:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wai Chun Bio-Technology Limited released a bilingual circular on 31 March 2026 outlining four key matters: (1) Major Transactions, (2) Discloseable Transactions, (3) an Advance to an Entity, and (4) the Notice of an Extraordinary General Meeting (EGM).</p>\n<p>The document is accessible on both the company’s website (www.0660.hk) and HKEX’s website (www.hkexnews.hk). Non-registered shareholders may request free printed copies through Union Registrars Limited, the Hong Kong branch share registrar, by written request or email.</p>\n<p>Shareholders holding shares via banks, brokers, custodians, nominees, or HKSCC Nominees Limited can opt to receive future corporate communications electronically by providing a functional email address to their respective intermediaries. If no email address is supplied, electronic notification will not be sent.</p>\n<p>Enquiries regarding the circular or the distribution arrangements can be directed to Union Registrars Limited at +852 2849 3399 during business hours, Monday to Friday (excluding Hong Kong public holidays).</p>\n<p>The circular’s release precedes the forthcoming EGM, details of which—including date, time, and venue—are provided within the published document.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00660","symbol_name":"玮俊生物科技","start_time":0,"source_url":"","article_id":"1179658578","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179658578","pubTimestamp":1774959787,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Wai Chun Bio-Technology Limited released a bilingual circular on 31 March 2026 outlining four key matters: (1) Major Transactions, (2) Discloseable Transactions, (3) an Advance to an Entity, and (4)...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00660":"玮俊生物科技"},"translate_title":"伟俊生物科技刊发通函，内容涵盖主要及须予披露交易、向实体垫款及即将举行的股东特别大会","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00660":1},"content_text":"Wai Chun Bio-Technology Limited released a bilingual circular on 31 March 2026 outlining four key matters: (1) Major Transactions, (2) Discloseable Transactions, (3) an Advance to an Entity, and (4) the Notice of an Extraordinary General Meeting (EGM).\nThe document is accessible on both the company’s website (www.0660.hk) and HKEX’s website (www.hkexnews.hk). Non-registered shareholders may request free printed copies through Union Registrars Limited, the Hong Kong branch share registrar, by written request or email.\nShareholders holding shares via banks, brokers, custodians, nominees, or HKSCC Nominees Limited can opt to receive future corporate communications electronically by providing a functional email address to their respective intermediaries. If no email address is supplied, electronic notification will not be sent.\nEnquiries regarding the circular or the distribution arrangements can be directed to Union Registrars Limited at +852 2849 3399 during business hours, Monday to Friday (excluding Hong Kong public holidays).\nThe circular’s release precedes the forthcoming EGM, details of which—including date, time, and venue—are provided within the published document.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}